Average Co-Inventor Count = 5.67
ph-index = 6
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Sunesis Pharmaceuticals, Inc. (14 from 63 patents)
2. Biogen Ma Inc. (3 from 250 patents)
3. Amgen Inc. (2 from 1,970 patents)
4. Millennium Pharmaceuticals Limited (2 from 850 patents)
5. Biogen Idec Ma Inc. (2 from 216 patents)
6. Millenium Pharmaceuticals, Inc. (1 from 36 patents)
7. Cannot Therapeutics, Inc. (1 from 1 patent)
17 patents:
1. 11572374 - N-cyano-7-azanorbornane derivatives and uses thereof
2. 11535660 - Modulators of G-protein coupled receptors
3. 11053226 - KRAS G12C inhibitors and methods of using the same
4. 10577374 - Bruton's tyrosine kinase inhibitors
5. 10107798 - Methods of chemotype evolution
6. 10030016 - Heterocyclic compounds useful as PDK1 inhibitors
7. 9873693 - Methods of treatment using pyridinonyl PDK1 inhibitors
8. 9790229 - Bruton's tyrosine kinase inhibitors
9. 9546165 - Heterocyclic compounds useful as PDK1 inhibitors
10. 9249146 - Bruton'S tyrosine kinase inhibitors
11. 9029359 - Heteroaryl Btk inhibitors
12. 8785440 - Bruton's tyrosine kinase inhibitors
13. 8778977 - Pyridinonyl PDK1 inhibitors
14. 7214487 - Methods for identifying compounds that modulate enzymatic activities by employing covalently bonded target-extender complexes with ligand candidates
15. 6919178 - Extended tethering approach for rapid identification of ligands